Dosidal · Switzerland
Bupropion XR Sandoz, Retardtabletten
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:68628 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 68628 atc: N06AX12 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 2023-12-12 term: zugelassen valid_until: 2028-12-11 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: N06AX12 authorisation_number: 68628 form: RETT holder: Sandoz Pharmaceuticals AG holder_partner_nr: 1006431 it_number: 01.06.0. name: Bupropion XR Sandoz, Retardtabletten state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d539jw8Hfm0Yp-n1Hs8_RAMG8tBRafEv04vlfQ4jNxRksJw0tioADXbfSOPnbkzBJx_6I6rQdN4K9jYGnQuAi0AbQVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/ch:authorisation:68628 · Related records in other markets · Dosidal